Survey on the Pharmacy Follow-up of Alli Purchasers

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Overweight

Treatments: Drug: Orlistat

Study type: Observational

Funder types: Industry

Identifiers

NCT01387243

W5350856

Details and patient eligibility

About

To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.

Enrollment: 80 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.

Trial design

80 participants in 1 patient group

60 mg Orlistat

Description:

Purchased by consumer

Treatment:

Drug: Orlistat